Silja Mordhorst

Silja Mordhorst

Auto-generated profile, based on publicly available information

Silja Mordhorst

Eberhard Karls University Tübingen Auf der Morgenstelle 8

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
SMSilja Mordhorst
Silja Mordhorst
JAJennifer N. Andexer
Jennifer N. Andexer
Covering: up to the beginning of 2020 Enzymes depending on cofactors are essential in many biosynthetic pathways of natural products. They are often involved in key steps: catalytic conversions that are difficult to achieve purely with synthetic organic chemistry. Hence, cofactor-dependent enzymes have great potential for biocatalysis, on the condition that a corresponding cofactor regeneration system is available. For some cofactors, these regeneration systems require multiple steps; such complex enzyme cascades/multi-enzyme systems are (still) challenging for in vitro biocatalysis. Further, artificial cofactor analogues have been synthesised that are more stable, show an altered reaction range, or act as inhibitors. The development of bio-orthogonal systems that can be used for the production of modified natural products in vivo is an ongoing challenge. In light of the recent progress in this field, this review aims to provide an overview of general strategies involving enzyme cofactors, cofactor analogues, and regeneration systems; highlighting the current possibilities for application of enzymes using some of the most common cofactors.

7 February 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
SMSilja Mordhorst
Silja Mordhorst
JSJutta Siegrist
Jutta Siegrist
MMMichael Müller
Michael Müller
MRMichael Richter
Michael Richter
JAJennifer N. Andexer
Jennifer N. Andexer

12 March 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
APAlice E. Parnell
Alice E. Parnell
SMSilja Mordhorst
Silja Mordhorst
FKFlorian Kemper
Florian Kemper
MGMariacarmela Giurrandino
Mariacarmela Giurrandino
JPJosh Prince
Josh Prince
PRPeter L. Roach
Peter L. Roach
Inorganic polyphosphate is a ubiquitous, linear biopolymer built of up to thousands of phosphate residues that are linked by energy-rich phosphoanhydride bonds. Polyphosphate kinases of the family 2 (PPK2) use polyphosphate to catalyze the reversible phosphorylation of nucleotide phosphates and are highly relevant as targets for new pharmaceutical compounds and as biocatalysts for cofactor regeneration. PPK2s can be classified based on their preference for nucleoside mono- or diphosphates or both. The detailed mechanism of PPK2s and the molecular basis for their substrate preference is unclear, which is mainly due to the lack of high-resolution structures with substrates or substrate analogs. Here, we report the structural analysis and comparison of a class I PPK2 (ADP-phosphorylating) and a class III PPK2 (AMP- and ADP-phosphorylating), both complexed with polyphosphate and/or nucleotide substrates. Together with complementary biochemical analyses, these define the molecular basis of nucleotide specificity and are consistent with a Mg2+ catalyzed in-line phosphoryl transfer mechanism. This mechanistic insight will guide the development of PPK2 inhibitors as potential antibacterials or genetically modified PPK2s that phosphorylate alternative substrates. Significance Polyphosphate kinases (PPKs) are involved in many metabolic processes in bacteria, including pathogenic species. As these enzymes are not present in animals, they are a prime target for the development of novel antibiotics. The detailed knowledge of the mechanism of action and structure–function relationships of these enzymes is of utmost importance for the identification and design of new pharmaceutically active compounds and the rational improvement of lead structures. In addition, PPKs use inexpensive and stable polyphosphate as a phosphate donor and phosphorylate nucleoside 5′-mono- as well as 5′-diphosphates. This makes them of special interest for application in ATP regeneration systems, which can be efficiently coupled to ATP-consuming enzymes in environmentally friendly and sustainable biotechnological processes.

27 March 2017 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
CSChristina Sommer‐Kamann
Christina Sommer‐Kamann
AFAlexander Fries
Alexander Fries
SMSilja Mordhorst
Silja Mordhorst
JAJennifer N. Andexer
Jennifer N. Andexer
MMMichael Müller
Michael Müller

6 October 2015 in ChemBioChem
Verified
Journal Article
Closed access
PDF file
JSJutta Siegrist
Jutta Siegrist
SASimon Aschwanden
Simon Aschwanden
SMSilja Mordhorst
Silja Mordhorst
LTLinda Thöny‐Meyer
Linda Thöny‐Meyer
MRMichael Richter
Michael Richter
JAJennifer N. Andexer
Jennifer N. Andexer

22 March 2021 in RSC Chemical Biology
Verified
Journal Article
Open access
PDF file
DPDésirée Popadić
Désirée Popadić
DMDipali Mhaindarkar
Dipali Mhaindarkar
MTMike H. N. Dang Thai
Mike H. N. Dang Thai
HHHelen Hailes
Helen Hailes
SMSilja Mordhorst
Silja Mordhorst
JAJennifer N. Andexer
Jennifer N. Andexer
The ubiquitous cofactor S-adenosyl-L-methionine (SAM) is part of numerous biochemical reactions in metabolism, epigenetics, and cancer development. As methylation usually improves physiochemical properties of compounds relevant for pharmaceutical use, the sustainable use of SAM as a methyl donor in biotechnological applications is an important goal. SAM-dependent methyltransferases are consequently an emerging biocatalytic tool for environmentally friendly and selective alkylations. However, SAM shows undesirable characteristics such as degradation under mild conditions and its stoichiometric use is economically not reasonable. Here, we report an optimised biomimetic system for the regeneration of SAM and SAM analogues consisting of effective nucleoside triphosphate formation and an additional L-methionine regeneration cycle without by-product accumulation. The bicyclic system uses seven enzymes, S-methylmethionine as methyl donor and a surplus of inorganic polyphosphate, along with catalytic amounts of L-methionine and cofactor building block reaching conversions of up to 99% (up to 200 turnovers). We also show that the cycle can be run with cofactor building blocks containing different purine and pyrimidine nucleobases, which can be fed in at the nucleoside or nucleotide stage. These alternative cofactors are in turn converted to the corresponding SAM analogues, which are considered to be a key for the development of bioorthogonal systems. In addition to purified enzymes, the bicyclic system can also be used with crude lysates highlighting its broad biocatalytic applicability.